The global cell culture media, sera, and reagents market size surpassed at US$ 5.2 billion in 2020 and to reach US$ 8.4 billion by 2027 with a CAGR of 5.8% from 2021 to 2027.
Contract research and manufacturing, and focus on stem cell research would expand the scope of cell culture,growing demand for biopharmaceuticals and artificial organs, and trend towards serum-free, specialty and customized media solutions are projected to drive the global cell culture media, sera, and reagents market during the forecast period.
The global cell culture media, sera and reagents market is witnessing impressive growth due to the increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life sciences industry, the cell culture market has witnessed significant growth in terms of scope as well as adoption by the end-users.
The double-digit growth in the biotechnology and biopharmaceutical industries is the major factor likely to boost the growth of the cell culture media, sera and reagents market in the near future.
Growing Demand for Biopharmaceuticals and Artificial Organs to Drive Market
Classical Media Segment to Dominate Market
Fetal Bovine to be Highly Lucrative Segment
North America to Dominate Global Market
Competitive Landscape
Market Segmentation
By Media Type
By Product
By Reagents
By Region
Scope of Report
VRR’s report on the global cell culture media, sera and reagents market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cell culture media, sera and reagents market for the period 2017–2027, considering 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cell culture media, sera and reagents market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cell culture media, sera and reagents market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a Protein-free of top-down and bottom-up approaches to study various phenomenon in the global Cell Culture Media, Sera and Reagents market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cell culture media, sera and reagents market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cell culture media, sera and reagents market.
The report delves into the competitive landscape of the global cell culture media, sera and reagents market. Key players operating in the global cell culture media, sera and reagents market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cell culture media, sera and reagents market that have been profiled in this report.
Key Questions Answered in Global Cell Culture Media, Sera and Reagents Market Report
Research Methodology
A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global Cell Culture Media, Sera and Reagents market and arrive at conclusions on its growth prospects. This research methodology is a Protein-free of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global Cell Culture Media, Sera and Reagents market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the Cell Culture Media, Sera and Reagents market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the Cell Culture Media, Sera and Reagents market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global Cell Culture Media, Sera and Reagents market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global Cell Culture Media, Sera and Reagents market more reliably and accurately.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, 2017–2027
5. Key Insights
5.1. Product Overview
5.2. Key Industry Developments
5.3. Emerging Trends in Cell Culture Media, Sera and Reagents Market
6. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, By Media Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Media Type, 2017–2027
6.3.1. Chemically-defined
6.3.2. Classical
6.3.3. Lysogeny Broth (LB)
6.3.4. Protein-free
6.3.5. Serum-free
6.3.6. Specialty
6.4. Market Attractiveness By Media Type
7. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, By Product
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Product, 2017–2027
7.3.1. Fetal Bovine
7.3.2. Newborn calf and adult bovine
7.3.3. Others
7.3.4. HPV
7.3.5. Meningococcal
7.3.6. Rotavirus
7.3.7. Measles and Rubella
7.3.8. Typhoid
7.3.9. Protein-free
7.3.10. Specialty
7.4. Market Attractiveness By Product
8. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, By Reagents
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Reagents, 2017–2027
8.3.1. Albumin
8.3.1.1. Human Serum Albumin
8.3.1.2. Bovine Serum Albumin
8.3.1.3. Recombinant Serum Albumin
8.3.2. Amino acids
8.3.3. Attachment factors
8.3.4. Growth Factors & Cytokines
8.3.4.1. Insulin-Like Growth Factors
8.3.4.2. Interleukins and Interferons
8.3.4.3. Tumor necrosis factors
8.3.4.4. Others
8.3.5. Protease Inhibitors
8.3.6. Others
8.3.6.1. Recombinant Trypsin
8.3.6.2. Porcine Trypsin
8.3.6.3. Thrombin
8.3.6.4. Miscellaneous Reagents
8.4. Market Attractiveness By Reagents
9. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Region
10. North America Cell Culture Media, Sera and Reagents Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast By Media Type, 2017–2027
10.2.1. Chemically-defined
10.2.2. Classical
10.2.3. Lysogeny Broth (LB)
10.2.4. Protein-free
10.2.5. Serum-free
10.2.6. Specialty
10.3. Market Value Forecast By Product, 2017–2027
10.3.1. Fetal Bovine
10.3.2. Newborn calf and adult bovine
10.3.3. Others
10.4. Market Value Forecast By Reagents, 2017–2027
10.4.1. Albumin
10.4.1.1. Human Serum Albumin
10.4.1.2. Bovine Serum Albumin
10.4.1.3. Recombinant Serum Albumin
10.4.2. Amino acids
10.4.3. Attachment factors
10.4.4. Growth Factors & Cytokines
10.4.4.1. Insulin-Like Growth Factors
10.4.4.2. Interleukins and Interferons
10.4.4.3. Tumor necrosis factors
10.4.4.4. Others
10.4.5. Protease Inhibitors
10.4.6. Others
10.4.6.1. Recombinant Trypsin
10.4.6.2. Porcine Trypsin
10.4.6.3. Thrombin
10.4.6.4. Miscellaneous Reagents
10.5. Market Value Forecast By Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Media Type
10.6.2. By Product
10.6.3. By Reagents
10.6.4. By Country
11. Europe Cell Culture Media, Sera and Reagents Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast By Media Type, 2017–2027
11.2.1. Chemically-defined
11.2.2. Classical
11.2.3. Lysogeny Broth (LB)
11.2.4. Protein-free
11.2.5. Serum-free
11.2.6. Specialty
11.3. Market Value Forecast By Product, 2017–2027
11.3.1. Fetal Bovine
11.3.2. Newborn calf and adult bovine
11.3.3. Others
11.4. Market Value Forecast By Reagents, 2017–2027
11.4.1. Albumin
11.4.1.1. Human Serum Albumin
11.4.1.2. Bovine Serum Albumin
11.4.1.3. Recombinant Serum Albumin
11.4.2. Amino acids
11.4.3. Attachment factors
11.4.4. Growth Factors & Cytokines
11.4.4.1. Insulin-Like Growth Factors
11.4.4.2. Interleukins and Interferons
11.4.4.3. Tumor necrosis factors
11.4.4.4. Others
11.4.5. Protease Inhibitors
11.4.6. Others
11.4.6.1. Recombinant Trypsin
11.4.6.2. Porcine Trypsin
11.4.6.3. Thrombin
11.4.6.4. Miscellaneous Reagents
11.5. Market Value Forecast By Country, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Media Type
11.6.2. By Product
11.6.3. By Reagents
11.6.4. By Country
12. Asia Pacific Cell Culture Media, Sera and Reagents Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast By Media Type, 2017–2027
12.2.1. Chemically-defined
12.2.2. Classical
12.2.3. Lysogeny Broth (LB)
12.2.4. Protein-free
12.2.5. Serum-free
12.2.6. Specialty
12.3. Market Value Forecast By Product, 2017–2027
12.3.1. Fetal Bovine
12.3.2. Newborn calf and adult bovine
12.3.3. Others
12.4. Market Value Forecast By Reagents, 2017–2027
12.4.1. Albumin
12.4.1.1. Human Serum Albumin
12.4.1.2. Bovine Serum Albumin
12.4.1.3. Recombinant Serum Albumin
12.4.2. Amino acids
12.4.3. Attachment factors
12.4.4. Growth Factors & Cytokines
12.4.4.1. Insulin-Like Growth Factors
12.4.4.2. Interleukins and Interferons
12.4.4.3. Tumor necrosis factors
12.4.4.4. Others
12.4.5. Protease Inhibitors
12.4.6. Others
12.4.6.1. Recombinant Trypsin
12.4.6.2. Porcine Trypsin
12.4.6.3. Thrombin
12.4.6.4. Miscellaneous Reagents
12.5. Market Value Forecast By Country, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Media Type
12.6.2. By Product
12.6.3. By Reagents
12.6.4. By Country
13. Latin America Cell Culture Media, Sera and Reagents Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast By Media Type, 2017–2027
13.2.1. Chemically-defined
13.2.2. Classical
13.2.3. Lysogeny Broth (LB)
13.2.4. Protein-free
13.2.5. Serum-free
13.2.6. Specialty
13.3. Market Value Forecast By Product, 2017–2027
13.3.1. Fetal Bovine
13.3.2. Newborn calf and adult bovine
13.3.3. Others
13.4. Market Value Forecast By Reagents, 2017–2027
13.4.1. Albumin
13.4.1.1. Human Serum Albumin
13.4.1.2. Bovine Serum Albumin
13.4.1.3. Recombinant Serum Albumin
13.4.2. Amino acids
13.4.3. Attachment factors
13.4.4. Growth Factors & Cytokines
13.4.4.1. Insulin-Like Growth Factors
13.4.4.2. Interleukins and Interferons
13.4.4.3. Tumor necrosis factors
13.4.4.4. Others
13.4.5. Protease Inhibitors
13.4.6. Others
13.4.6.1. Recombinant Trypsin
13.4.6.2. Porcine Trypsin
13.4.6.3. Thrombin
13.4.6.4. Miscellaneous Reagents
13.5. Market Value Forecast By Country, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Media Type
13.6.2. By Product
13.6.3. By Reagents
13.6.4. By Country
14. Middle East & Africa Cell Culture Media, Sera and Reagents Market Analysis and Forecast
14.1. Introduction
14.2. Market Value Forecast By Media Type, 2017–2027
14.2.1. Chemically-defined
14.2.2. Classical
14.2.3. Lysogeny Broth (LB)
14.2.4. Protein-free
14.2.5. Serum-free
14.2.6. Specialty
14.3. Market Value Forecast By Product, 2017–2027
14.3.1. Fetal Bovine
14.3.2. Newborn calf and adult bovine
14.3.3. Others
14.4. Market Value Forecast By Reagents, 2017–2027
14.4.1. Albumin
14.4.1.1. Human Serum Albumin
14.4.1.2. Bovine Serum Albumin
14.4.1.3. Recombinant Serum Albumin
14.4.2. Amino acids
14.4.3. Attachment factors
14.4.4. Growth Factors & Cytokines
14.4.4.1. Insulin-Like Growth Factors
14.4.4.2. Interleukins and Interferons
14.4.4.3. Tumor necrosis factors
14.4.4.4. Others
14.4.5. Protease Inhibitors
14.4.6. Others
14.4.6.1. Recombinant Trypsin
14.4.6.2. Porcine Trypsin
14.4.6.3. Thrombin
14.4.6.4. Miscellaneous Reagents
14.5. Market Value Forecast By Country, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Media Type
14.6.2. By Product
14.6.3. By Reagents
14.6.4. By Country
15. Competition Landscape
15.1. Market Share Analysis By Company (2019)
15.2. Company Profiles
15.2.1. Becton, Dickinson and Company
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Growth Strategies
15.2.1.3. SWOT Analysis
15.2.2. Corning Life Sciences B.V.
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Growth Strategies
15.2.2.3. SWOT Analysis
15.2.3. EMD Millipore
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Growth Strategies
15.2.3.3. SWOT Analysis
15.2.4. GE Healthcare
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Growth Strategies
15.2.4.3. SWOT Analysis
15.2.5. Lonza Group Ltd
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Growth Strategies
15.2.5.3. SWOT Analysis
15.2.6. PromoCell GmbH
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Growth Strategies
15.2.6.3. SWOT Analysis
15.2.7. Thermo Fisher Scientific, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Growth Strategies
15.2.7.3. SWOT Analysis
15.2.8. Merck & Co, Inc.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Growth Strategies
15.2.8.3. SWOT Analysis
15.2.9. VWR International, LLC
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Growth Strategies
15.2.9.3. SWOT Analysis
15.2.10. Wheaton Industries, Inc.
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Growth Strategies
15.2.10.3. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers